A 12-member steering committee co-chaired by Claridge CEO Pierre Boivin and UdeM Rector Guy Breton will guide the process.
Julie Hlavacek-Larrondo and Marie-Lou Gendron Marsolais, two researchers at Université de Montréal and the CRAQ, helped find the phenomenon through their work on radio waves.
A Trump Dividend for Canada? Maybe in Its A.I. Industry
For his doctorate, Sylvain Gaudet is studying how to help athletes cut down on injuries during training.
For her doctorate, Valentine Crosset is probing how the terrorist group goes about creating and organizing its online propaganda.
Morgane Bonamy hopes these misunderstood carnivores will someday be reintroduced to their natural habitat in northern Quebec.
Julie Saint-Laurent studies post-traumatic stress disorder among workers who’ve returned from abroad.
For his doctorate, Simon Laperrière explores the phenomenon of “fan theories” about major feature movies.
As part of his PhD, Vincent Denault explores why witnesses lie in court.
Metformin shows promise to treat Fragile X syndrome, an inherited form of intellectual disability.
An international team of astrophysicists that includes researchers at iREx has discovered that one of the brown dwarfs nearest to our Sun is actually a planetary-mass object.
The World Health Summit Regional Meeting identified 12 priority actions aimed at improving health and healthcare across the world.
Chemists from Italy and Canada specializing in nanotechnology create a molecular slingshot that could shoot drugs at precise locations in the human body once triggered by specific disease markers.
College students and other 18-to-25's aren't getting the attention they need to avoid taking up smoking, says PhD candidate Thierry Gagné, who wrote a paper on the subject.
Getting the right organ to the right recipient is always a challenge. UdeM scientists think artificial intelligence can help.
The U.S. tech giant announces a new artificial-intelligence laboratory to boost its projects with the Montreal Institute for Learning Algorithms.
Dr. André Veillette and his team have discovered why immunotherapy would work in some patients and not at all in others. This finding is published today in Nature.
Campus Montréal’s major fundraising campaign has raised $581 million in philanthropic donations, beating its target of $500 million.
At an international conference, CHU Sainte-Justine immunologist Hugo Soudeyns talks about the ongoing HIV/AIDS epidemic.